Life-long Tele-monitoring of Patients With Type 2 Diabetes Mellitus in Central Greece

NCT01498367 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2015-02-18

No results posted yet for this study

Summary

To evaluate whether patients with type 2 diabetes mellitus can be followed by simplified, centralized and large scale tele-monitoring of blood glucose levels and blood pressure, and whether this intervention produces health and economic benefits when introduced without major changes to the existing organization of a large tertiary care center.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

PROCEDURE

Telemonitoring of patients with diabetes type 2

Telemonitoring of the patients's blood glucose level measurements using a the tele-glucose meter

Sponsors & Collaborators

  • Ministry for Health and Social Solidarity, Greece

    collaborator OTHER
  • Municipality of Trikala, Greece

    collaborator OTHER
  • e-Trikala S.A.

    collaborator INDUSTRY
  • Cities Net SA

    collaborator INDUSTRY
  • Institute of Biomedical Research & Technology, Larissa, Greece

    collaborator OTHER
  • Institute of Communications and Computer Systems, Athens, Greece

    collaborator OTHER
  • Alexander Technological Educational Institute, Thessaloniki, Greece

    collaborator OTHER
  • University of Macedonia, Thessaloniki, Greece

    collaborator OTHER
  • University of Thessaly

    collaborator OTHER
  • Regional Health Authority of Sterea & Thessaly

    lead OTHER_GOV

Principal Investigators

  • Georgios Koukoulis, MD, PhD · Endocrinology and Metabolic Diseases Department - Regional University Hospital of Larisa

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-12-31
Completion
2014-01-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01498367 on ClinicalTrials.gov